LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Doubly-robust estimator of the difference in restricted mean times lost with competing risks data

Photo from wikipedia

In the context of competing risks data, the subdistribution hazard ratio has limited clinical interpretability to measure treatment effects. An alternative is the difference in restricted mean times lost (RMTL),… Click to show full abstract

In the context of competing risks data, the subdistribution hazard ratio has limited clinical interpretability to measure treatment effects. An alternative is the difference in restricted mean times lost (RMTL), which gives the mean time lost to a specific cause of failure between treatment groups. In non-randomized studies, the average causal effect is conventionally used for decision-making about treatment and public health policies. We show how the difference in RMTL can be estimated by contrasting the integrated cumulative incidence functions from a Fine-Gray model. We also show how the difference in RMTL can be estimated by using inverse probability of treatment weighting and contrasts between weighted non-parametric estimators of the area below the cumulative incidence. We use pseudo-observation approaches to estimate both component models and we integrate them into a doubly-robust estimator. We demonstrate that this estimator is consistent when either component is correctly specified. We conduct simulation studies to assess its finite-sample performance and demonstrate its inherited consistency property from its component models. We also examine the performance of this estimator under varying degrees of covariate overlap and under a model misspecification of nonlinearity. We apply the proposed method to assess biomarker-treatment interaction in subpopulations of the POPLAR and OAK randomized controlled trials of second-line therapy for advanced non-small-cell lung cancer.

Keywords: risks data; difference restricted; treatment; competing risks; difference; estimator

Journal Title: Statistical Methods in Medical Research
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.